Chronic proliferative hepatitis in A/JCr mice associated with persistent Helicobacter hepaticus infection: a model of helicobacter-induced carcinogenesis - PubMed (original) (raw)
Chronic proliferative hepatitis in A/JCr mice associated with persistent Helicobacter hepaticus infection: a model of helicobacter-induced carcinogenesis
J G Fox et al. Infect Immun. 1996 May.
Abstract
Helicobacter hepaticus causes hepatitis in selected strains of mice and in A/JCr mice is linked to liver cancer. To analyze whether H. hepaticus persists in specified ecological niches, to determine whether biomarkers of infection exist, and to analyze the influence of H. hepaticus on hepatocyte proliferation, a longitudinal study of H. hepaticus-infected A/JCr mice was undertaken. A/JCr mice were serially euthanatized from 3 through 18 months and surveyed by enzyme-linked immunosorbent assay; bacterial culture of liver, colon, and cecum; histology; electron microscopy; hepatocyte proliferation indices determined by using 5-bromo-2'-deoxyuridine; and measurement of the liver enzyme alanine aminotransferase. In infected animals throughout the 18-month study, H. hepaticus was consistently isolated from the lower bowel but only sporadically from the liver. By electron microscopy, H. hepaticus was noted infrequently and only in bile canaliculi. Infected mice, particularly males, showed chronic inflammation; oval cell, Kupffer cell, and Ito cell hyperplasia; hepatocytomegaly; and bile duct proliferation. The inflammatory and necrotizing lesion was progressive and involved the hepatic parenchyma, portal triads, and intralobular venules. Hepatic adenomas were noted only in male mice, whereas 5-bromo-2'-deoxyuridine proliferation indices were markedly increased in both sexes, but especially in males, compared to control A/J mice. Infected mice also developed sustained anti-H. hepaticus serum immunoglobulin G antibody responses and elevated alanine aminotransferase levels. H. hepaticus, which persists in the lower bowels and livers of A/JCr mice, is associated with a chronic proliferative hepatitis, and hepatomas in selected male mice indicate that this novel bacterium may cause an increased risk of hepatic cancer induction in susceptible strains of mice. This murine model should prove useful in dissecting the molecular events operable in the development of neoplasms induced by bacteria belonging to this expanding genera of pathogenic Helicobacter species.
Similar articles
- SCID/NCr mice naturally infected with Helicobacter hepaticus develop progressive hepatitis, proliferative typhlitis, and colitis.
Li X, Fox JG, Whary MT, Yan L, Shames B, Zhao Z. Li X, et al. Infect Immun. 1998 Nov;66(11):5477-84. doi: 10.1128/IAI.66.11.5477-5484.1998. Infect Immun. 1998. PMID: 9784560 Free PMC article. - Persistent hepatitis and enterocolitis in germfree mice infected with Helicobacter hepaticus.
Fox JG, Yan L, Shames B, Campbell J, Murphy JC, Li X. Fox JG, et al. Infect Immun. 1996 Sep;64(9):3673-81. doi: 10.1128/iai.64.9.3673-3681.1996. Infect Immun. 1996. PMID: 8751916 Free PMC article. - Liver tumorigenesis by Helicobacter hepaticus: considerations of mechanism.
Canella KA, Diwan BA, Gorelick PL, Donovan PJ, Sipowicz MA, Kasprzak KS, Weghorst CM, Snyderwine EG, Davis CD, Keefer LK, Kyrtopoulos SA, Hecht SS, Wang M, Anderson LM, Rice JM. Canella KA, et al. In Vivo. 1996 May-Jun;10(3):285-92. In Vivo. 1996. PMID: 8797029 Review. - [Role of Helicobacter species in hepatobiliary diseases].
Rasmussen ME, Lauritsen LE, Andersen LP. Rasmussen ME, et al. Ugeskr Laeger. 2008 Jun 2;170(23):2010-5. Ugeskr Laeger. 2008. PMID: 18534163 Review. Danish.
Cited by
- Validation of Multiplex PCR and Serology Detecting Helicobacter Species in Mice.
Butt J, Schmitz M, Berkus B, Schmidt K, Höfler D. Butt J, et al. Microorganisms. 2023 Jan 18;11(2):249. doi: 10.3390/microorganisms11020249. Microorganisms. 2023. PMID: 36838214 Free PMC article. - Helicobacter hepaticus augmentation triggers Dopaminergic degeneration and motor disorders in mice with Parkinson's disease.
Ahn EH, Liu X, Alam AM, Kang SS, Ye K. Ahn EH, et al. Mol Psychiatry. 2023 Mar;28(3):1337-1350. doi: 10.1038/s41380-022-01910-2. Epub 2022 Dec 21. Mol Psychiatry. 2023. PMID: 36543925 - Helicobacter hepaticus Infection Promotes the Progression of Liver Preneoplasia in BALB/c Mice via the Activation and Accumulation of High-Mobility Group Box-1.
Cao S, Miao J, Qian M, Zhu C, Ding S, Yin J, Zhu L, Zhang Q. Cao S, et al. Front Microbiol. 2022 Jan 3;12:789752. doi: 10.3389/fmicb.2021.789752. eCollection 2021. Front Microbiol. 2022. PMID: 35046917 Free PMC article. - From DNA Damage to Cancer Progression: Potential Effects of Cytolethal Distending Toxin.
Lai YR, Chang YF, Ma J, Chiu CH, Kuo ML, Lai CH. Lai YR, et al. Front Immunol. 2021 Nov 15;12:760451. doi: 10.3389/fimmu.2021.760451. eCollection 2021. Front Immunol. 2021. PMID: 34868002 Free PMC article. Review. - Helicobacter hepaticus is required for immune targeting of bacterial heat shock protein 60 and fatal colitis in mice.
Friedrich V, Forné I, Matzek D, Ring D, Popper B, Jochum L, Spriewald S, Straub T, Imhof A, Krug A, Stecher B, Brocker T. Friedrich V, et al. Gut Microbes. 2021 Jan-Dec;13(1):1-20. doi: 10.1080/19490976.2021.1882928. Gut Microbes. 2021. PMID: 33550886 Free PMC article.
References
- Lancet. 1984 Jun 16;1(8390):1311-5 - PubMed
- Lab Anim Sci. 1996 Feb;46(1):15-20 - PubMed
- Gastroenterology. 1989 Feb;96(2 Pt 2 Suppl):615-25 - PubMed
- Gastroenterology. 1989 Feb;96(2 Pt 1):414-20 - PubMed
- J Clin Microbiol. 1989 Jan;27(1):225-6 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases